Company / Current Assets
Avidity Biosciences, Inc. Current Assets History
FY2019-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Current Assets
$1.8B
FY2025
5-year range
$411.1M / $1.8B
FY2021-FY2025
Trend
+16.6%
vs FY2024
Sector context
#34 of 213
Health Care
What the data says
Avidity Biosciences, Inc.'s current assets of $1.8B is higher than 84% of companies in the Health Care sector (FY2025). Improved from $611M to $1.8B over the past 2 years.
Based on SEC 10-K filings.
$1.8B in FY2025 with a 5-year CAGR of +40.2%. Top quartile in the Health Care sector.
Improved from $611M to $1.8B over the past 2 years.
Health Care sector context is included.
Current Assets over time
Growth rates
- 3-Year CAGR
- +42.4%
- 5-Year CAGR
- +40.2%
- 10-Year CAGR
- -
Sector benchmark
Top 16% in Health CareTop 16% of 213This company $1.8B Sector average $2.5B
▼
-28.7% below sector average
Key checks
Key Insights
- 5-year CAGR of +40.2%, indicating consistent growth.
- In FY2025, current assets increased 16.6% year-over-year.
- Ranks #34 out of 213 companies in the Health Care sector.
- Lowest current assets in the period was in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 2/9 (multiple financial health concerns)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Current AssetsValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $1.8B | +16.6% |
| FY2024 | $1.5B | +152.3% |
| FY2023 | $611.3M | -1.9% |
| FY2022 | $622.9M | +51.5% |
| FY2021 | $411.1M | +24.0% |
| FY2020 | $331.7M | +246.7% |
| FY2019 | $95.7M | - |
| FY2018 | - | - |
As of FY2025 · SEC 10-K · Updated Feb 28, 2026